DCP
AGN

DSM Capital Partners’s Allergan Inc AGN Stock Holding History

DSM Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,217,422
Closed -$217M – 76
2014
Q3 		$217M Buy
+1,217,422
New +$202M 4.31% 6

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $19.5B AUM 2.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DSM Capital Partners's AGN Position: Q4 2014 in Review

DSM Capital Partners sold out of Allergan Inc (AGN) in Q4 2014, closing a stake of 1,217,422 shares — an estimated $217M sold.

DSM Capital Partners first reported a position in AGN in Q3 2014 and held it in 1 quarter. The position peaked at $217M in Q3 2014. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • DSM Capital Partners reported no remaining Allergan Inc position as of Q4 2014 after selling out during the quarter.
  • DSM Capital Partners sold 1,217,422 Allergan Inc shares in Q4 2014, an estimated $217M.
  • DSM Capital Partners first reported a position in Allergan Inc in Q3 2014 and held it in 1 quarter.
  • DSM Capital Partners's Allergan Inc position peaked at $217M in Q3 2014.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on DSM Capital Partners's 13F filing for Q4 2014, filed 12 Feb 2015.